Cargando…

‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention

BACKGROUND: Breast cancer is a multifactorial disease with the highest incidence rates amongst all cancer types. Further, high levels of circulating tumour cells are a characteristic of breast cancer patients demonstrating a particular predisposition to the development of breast cancer metastatic di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debald, Manuel, Yeghiazaryan, Kristina, Cebioglu, Melanie, Kuhn, Walther, Schild, Hans H, Golubnitschaja, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847171/ https://www.ncbi.nlm.nih.gov/pubmed/24228816 http://dx.doi.org/10.1186/1878-5085-4-22

Ejemplares similares

“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures
por: Cebioglu, Melanie, et al.
Publicado: (2010)

Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Inadequate diabetic care: global figures cry for preventive measures and personalized treatment
por: George, Babitha, et al.
Publicado: (2010)

Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours
por: Golubnitschaja, Olga, et al.
Publicado: (2016)

Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs
por: Yeghiazaryan, Kristina, et al.
Publicado: (2010)

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments
por: Yeghiazaryan, Kristina, et al.
Publicado: (2011)

Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Innovative strategies for prediction and targeted prevention of glaucoma in healthy vasospastic individuals: context of neurodegenerative pathologies
por: Yeghiazaryan, Kristina, et al.
Publicado: (2014)

Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?
por: Golubnitschaja, Olga, et al.
Publicado: (2010)

Non-invasive proteomics—thinking about personalized breast cancer screening and treatment
por: Debald, Manuel, et al.
Publicado: (2010)

Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes
por: Yeghiazaryan, Kristina, et al.
Publicado: (2009)

Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations
por: Goldstein, Elisha, et al.
Publicado: (2020)

Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice
por: Schnabel, Renate B, et al.
Publicado: (2022)

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA
por: Zaleski, Martin, et al.
Publicado: (2018)

Lipofilling effects after breast cancer surgery in post-radiation patients: an analysis of results and algorithm proposal
por: Debald, Manuel, et al.
Publicado: (2017)

Suspected undiagnosed ADRD among Middle Eastern and North African Americans
por: Kindratt, Tiffany Billmeier, et al.
Publicado: (2023)

Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia
por: Jönsson, Andreas, et al.
Publicado: (2018)

Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
por: Ayub, Tiyasha H., et al.
Publicado: (2015)

Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
por: Qian, Shehua, et al.
Publicado: (2019)

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale
por: Golubnitschaja, Olga
Publicado: (2010)

Correction: High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia
Publicado: (2019)

Superficial temperature distribution patterns before and after physical activity in school children are indicative for personalized exercise coaching and disease prevention
por: Dębiec-Bąk, Agnieszka, et al.
Publicado: (2021)

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine
por: Golubnitschaja, Olga
Publicado: (2013)

Time for new guidelines in advanced healthcare: the mission of The EPMA Journal to promote an integrative view in predictive, preventive and personalized medicine
por: Golubnitschaja, Olga
Publicado: (2012)

Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine
por: Golubnitschaja, Olga
Publicado: (2010)

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer
por: Renzi, Cristina, et al.
Publicado: (2020)

Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2018)

Oral Manifestations: A Reliable Indicator for Undiagnosed Diabetes Mellitus Patients
por: Shahbaz, Maliha, et al.
Publicado: (2022)

Undiagnosing: Correcting the medical record to prevent over-intervention
por: Hosking, Sarah M., et al.
Publicado: (2019)

Undiagnosed Hypertension and Undiagnosed Type 2 Diabetes among Overweight and Obese Marshallese Participants in a Diabetes Prevention Program
por: McElfish, Pearl A., et al.
Publicado: (2021)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0sj9vhglfd864ijd1jnf8dsts3